Supernus Pharmaceuticals Inc Logo

Supernus Pharmaceuticals Inc (SUPN): Eigentümerstruktur

Takani Score ?
26.6

Preis (29.10.2026)52W Hoch52W Tief
41,84 US Dollar59,68 US Dollar37,54 US Dollar
Analysten KonsensBuy Outperform Hold Underperform Sell
60,5 US Dollar3 0 1 0 0
Externe Analystenschätzungen (Quelle: EODHD). Keine Anlageberatung, keine Anlageempfehlung von Takani.
#SharesShort [%] Short Ratio
58.224.1438,51 5,36

Eigentümerstruktur

Analyse der Aktionärsstruktur und institutionellen Investoren

Unternehmensdaten

Grundlegende Informationen

Grunddaten

Name Supernus Pharmaceuticals Inc
Mitarbeiter 778
Handelsplatz NASDAQ
Ticker Symbol SUPN
IPO Datum 2012-05-01
Adresse 9715 Key West Avenue, Rockville, MD, United States, 20850

Unternehmensführung

RangNamePosition
1Mr. Jack A. Khattar M.B.A.Founder, President, CEO, Secretary & Director
2Mr. Timothy C. DecSenior VP & CFO
3Dr. Padmanabh P. Bhatt Ph.D.Chief Scientific Officer & Senior VP of Intellectual Property
4Mr. Frank MottolaSenior VP & Chief Technology Operations Officer
5Dr. Jonathan Rubin M.B.A., M.D.Senior VP of Research & Development and Chief Medical Officer
6Mr. Kevin T. Anderson Esq.Compliance Officer
7Mr. Taylor RaifordSenior Vice President of Sales
8Dr. William Todd Horich M.B.A., Ph.D.Senior VP & Chief Commercial Officer
9Dr. Bryan A. Roecklein Ph.D.Senior VP & Chief Business Officer
10Mr. Jeff BozickSenior Vice President of Supply Chain

Aktionärsverteilung

Aufteilung der Investoren

Größte Investoren

RangInhaberAnteileWert
1BlackRock Inc16,06%0,39 Mrd. USD
2Millennium Management LLC6,62%0,16 Mrd. USD
3Vanguard Portfolio Management, LLC5,68%0,14 Mrd. USD
4Armistice Capital, LLC4,54%0,11 Mrd. USD
5Vanguard Capital Management, LLC4,32%0,11 Mrd. USD
6State Street Corp4,22%0,10 Mrd. USD
7Delaware Management Holdings Inc4,08%0,10 Mrd. USD
8Dimensional Fund Advisors, Inc.3,57%0,09 Mrd. USD
9Geode Capital Management, LLC2,70%0,07 Mrd. USD
10Stephens Inv Mgmt Group LLC2,55%0,06 Mrd. USD
11Renaissance Technologies Corp2,54%0,06 Mrd. USD
12Loomis, Sayles & Company LP2,53%0,06 Mrd. USD
13Citadel Advisors Llc2,36%0,06 Mrd. USD
14Two Sigma Investments LLC2,03%0,05 Mrd. USD
15GW&K Investment Management, LLC1,78%0,04 Mrd. USD
16Sofinnova Ventures1,78%0,04 Mrd. USD
17Qube Research & Technologies1,58%0,04 Mrd. USD
18Morgan Stanley - Brokerage Accounts1,51%0,04 Mrd. USD
19The Goldman Sachs Group Inc1,41%0,03 Mrd. USD
20D. E. Shaw & Co LP1,32%0,03 Mrd. USD